Cerecin Inc.
New Filing
CIK: 0001293610·Biotechnology·DELAWARE·Filed: Jun 25, 2024
Total Offering
$7,000,000
Amount Sold
$3,740,000
Investors
10
First Sale
Jun 10, 2024
Offering Details
- Type
- Debt, Other: Convertible promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversion
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Nicholas Charles Stacey | Related Person |
| Samuel T. Henderson | Related Person |
| Jerris Knaisch | Related Person |
| Claude Nash | Related Person |
| Wolfgang Reichenberger | Related Person |
| Hans-Juergen Woerle | Related Person |
| KiKab Kim | Related Person |
| Dilpreet Singh | Related Person |
| Rahul Rajashekar | Related Person |
Company
SEC Filing
0001293610-24-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free